Clinical Trial Update: Topical Nasal Fluticasone Propionate in the Control of Allergic Rhinitis SymptomsPerene [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating topical nasal fluticasone propionate for control of perennial allergic rhinitis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• fluticasone propionate (topical nasal) (fluticasone propionate)

Snippet

Sponsor: Libbs Farmacêutica LTDA | Conditions: Perennial Allergic Rhinitis | Phase 3 | Status: COMPLETED